Total Payments
$5,162
2024 Payments
$173.74
Companies
29
Transactions
239
Medicare Patients
3,050
Medicare Billing
$200,902
Payment Breakdown by Category
Food & Beverage$4,012 (77.7%)
Travel$1,149 (22.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,012 | 237 | 77.7% |
| Travel and Lodging | $1,149 | 2 | 22.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $1,797 | 6 | $0 (2017) |
| PFIZER INC. | $458.14 | 37 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $369.91 | 25 | $0 (2023) |
| GlaxoSmithKline, LLC. | $348.84 | 26 | $0 (2023) |
| Allergan, Inc. | $263.91 | 23 | $0 (2020) |
| Novo Nordisk Inc | $242.09 | 18 | $0 (2024) |
| ABBVIE INC. | $227.75 | 12 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $218.49 | 13 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $181.58 | 10 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $139.61 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $173.74 | 10 | ABBVIE INC. ($84.99) |
| 2023 | $275.10 | 15 | Novartis Pharmaceuticals Corporation ($69.88) |
| 2022 | $447.62 | 26 | AstraZeneca Pharmaceuticals LP ($103.73) |
| 2021 | $219.50 | 12 | PFIZER INC. ($48.79) |
| 2020 | $168.33 | 10 | GlaxoSmithKline, LLC. ($41.48) |
| 2019 | $232.39 | 19 | PFIZER INC. ($156.80) |
| 2018 | $301.52 | 23 | GlaxoSmithKline, LLC. ($55.49) |
| 2017 | $3,343 | 124 | BOSTON SCIENTIFIC CORPORATION ($1,797) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 10 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/06/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: RESPIRATORY | ||||||
| 02/03/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: DIABETES | ||||||
| 02/02/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/31/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Respiratory | ||||||
| 01/30/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/26/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Diabetes | ||||||
| 01/23/2017 | PFIZER INC. | VIAGRA (Drug), CHANTIX, ELIQUIS | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 01/21/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/19/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: DIABETES | ||||||
| 01/13/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: DIABETES | ||||||
| 01/09/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Central Nervous System (CNS) | ||||||
| 01/03/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Diabetes | ||||||
| 01/03/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $0.30 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 744 | 1,024 | $129,961 | $61,296 |
| 2022 | 6 | 221 | 221 | $23,293 | $13,054 |
| 2021 | 10 | 899 | 1,294 | $134,113 | $66,059 |
| 2020 | 10 | 1,186 | 1,745 | $145,050 | $60,492 |
Total Patients
3,050
Total Services
4,284
Medicare Billing
$200,902
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 223 | 429 | $75,075 | $32,839 | 43.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 142 | 142 | $28,826 | $16,917 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 80 | $10,042 | $4,403 | 43.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 100 | 101 | $4,447 | $2,965 | 66.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 99 | 100 | $3,700 | $2,188 | 59.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 69 | 120 | $4,800 | $1,142 | 23.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 13 | $2,380 | $589.31 | 24.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 28 | $504.00 | $226.80 | 45.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 11 | $187.00 | $24.20 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 62 | $10,230 | $5,548 | 54.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $6,699 | $4,182 | 62.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 44 | 44 | $1,936 | $1,230 | 63.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 16 | $1,920 | $956.08 | 49.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 44 | 44 | $1,628 | $927.96 | 57.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 22 | 22 | $880.00 | $209.44 | 23.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 247 | 479 | $75,203 | $35,959 | 47.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 134 | 134 | $27,202 | $17,085 | 62.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 104 | $11,024 | $5,914 | 53.6% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 133 | 133 | $4,921 | $2,730 | 55.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 133 | 133 | $5,852 | $2,153 | 36.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 75 | 134 | $5,360 | $1,301 | 24.3% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 13 | 15 | $2,550 | $609.48 | 23.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 45 | 48 | $864.00 | $144.00 | 16.7% |
| 81002 | Urinalysis, manual test | Office | 2021 | 20 | 25 | $425.00 | $87.00 | 20.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 21 | 89 | $712.00 | $77.12 | 10.8% |
About Dr. Matthew Mark, MD
Dr. Matthew Mark, MD is a Family Medicine healthcare provider based in Bedford, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881782936.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Mark, MD has received a total of $5,162 in payments from pharmaceutical and medical device companies, with $173.74 received in 2024. These payments were reported across 239 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,012).
As a Medicare-enrolled provider, Mark has provided services to 3,050 Medicare beneficiaries, totaling 4,284 services with total Medicare billing of $200,902. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bedford, OH
- Active Since 10/11/2006
- Last Updated 01/08/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1881782936
Products in Payments
- WATCHMAN (Device) $1,797
- CHANTIX (Drug) $193.68
- FARXIGA (Drug) $184.13
- VRAYLAR (Drug) $145.40
- ENTRESTO (Drug) $120.41
- TOUJEO (Drug) $105.85
- BREZTRI (Drug) $104.48
- LINZESS (Drug) $97.38
- Victoza (Drug) $94.37
- TRELEGY ELLIPTA (Drug) $92.59
- VIAGRA (Drug) $89.98
- ANORO (Drug) $82.29
- BREO (Drug) $81.91
- JARDIANCE (Drug) $80.79
- JANUVIA (Drug) $71.43
- Myrbetriq (Drug) $70.01
- Trintellix (Drug) $69.56
- ELIQUIS (Drug) $69.10
- SYMBICORT (Drug) $67.62
- UBRELVY (Drug) $67.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bedford
Munawar Haider, Md, MD
Family Medicine — Payments: $14,495
Family Medicine $14,495
Vasu Nalajala, Md, MD
Family Medicine — Payments: $13,823
Family Medicine $13,823
Dr. Charles Cook, D.o, D.O
Family Medicine — Payments: $12,048
Family Medicine $12,048
Dr. Kara Matala, D.o, D.O
Family Medicine — Payments: $11,758
Family Medicine $11,758
Mrs. Uzoamaka Obinabo, M.d, M.D
Family Medicine — Payments: $9,408
Family Medicine $9,408
Diane Rowell, Md, MD
Family Medicine — Payments: $8,868
Family Medicine $8,868